Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
US11439632B2 · kind B2 · utility
1Cited by
33References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 4, 2019 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Oct 7, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2818
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for administering immunotherapy to a subject in need thereof and for treating a subject in need thereof, where in the methods the subject is administered an effective amount of an inhibitor of nNOS for inducing an immunotherapeutic response in the subject and for treating the subject. The disclosed methods and composition may be utilized for treating a subject having a cell proliferative disease or disorder such as melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.